NEERVANNAN SESHADRI (Chief Operating Officer) sold 3.5% of their position (2.99K shares) of TARSUS PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $199.5K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/24/2026ACC: 0001827584-26-000011
Officer· Chief Operating Officer
Since Oct 2020
-2.99K
Net shares
Net seller
$199.5K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
2.99K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−2.99K
Price / share
$66.75
Trade value
$199.52K
% of position
3.5%
3/20/2026
85.78K→82.79K
Total
Net shares
−2.99K
Net value
-$199.52K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/20/2026 | S · Sale | −2.99K | $66.75 | $199.52K | 3.5% | 85.78K | 82.79K |
| Total | −2.99K | -$199.52K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned475.00
Total
475.00 indirect475.00
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 475.00 | Indirect |
| Total | 475.00 | 475.00 indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported